The enhancement allows members to receive generic versions of certain specialty medications at a $0 copay and has the potential to provide an average savings of up to $40,000 annually.
Driven by a reduction in COVID-19 vaccines and testing revenue, as well as store closures, Rite Aid’s retail pharmacy segment revenues decreased over the prior-year quarter.